Cargando…
Accelerated pharmaceutical protein development with integrated cell free expression, purification, and bioconjugation
The use of living cells for the synthesis of pharmaceutical proteins, though state-of-the-art, is hindered by its lengthy process comprising of many steps that may affect the protein’s stability and activity. We aimed to integrate protein expression, purification, and bioconjugation in small volumes...
Autores principales: | Richardson, Dominique, Itkonen, Jaakko, Nievas, Julia, Urtti, Arto, Casteleijn, Marco G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086869/ https://www.ncbi.nlm.nih.gov/pubmed/30097621 http://dx.doi.org/10.1038/s41598-018-30435-4 |
Ejemplares similares
-
Characterization, Stability, and In Vivo Efficacy Studies of Recombinant Human CNTF and Its Permeation into the Neural Retina in Ex Vivo Organotypic Retinal Explant Culture Models
por: Itkonen, Jaakko, et al.
Publicado: (2020) -
Pullulan Based Bioconjugates for Ocular Dexamethasone Delivery
por: Kicková, Eva, et al.
Publicado: (2021) -
Codon optimization and factorial screening for enhanced soluble expression of human ciliary neurotrophic factor in Escherichia coli
por: Itkonen, Jaakko M, et al.
Publicado: (2014) -
Assessment of recombinant protein production in E. coli with Time-Gated Surface Enhanced Raman Spectroscopy (TG-SERS)
por: Kögler, Martin, et al.
Publicado: (2020) -
Enzymatic Bioconjugation:
A Perspective from the Pharmaceutical
Industry
por: Debon, Aaron, et al.
Publicado: (2023)